CHARAC SECURES £1M INVESTMENT FROM WORLD-CLASS MEDICATION PLATFORM MEDADVISOR TO DRIVE ITS INTERNATIONAL GROWTH
LONDON, Nov. 28, 2023 /PRNewswire/ -- Leading healthcare SaaS provider Charac today announces a ground-breaking partnership with world-class medication management platform MedAdvisor Solutions (ASX:MDR). The deal with Australia-based MedAdvisor allows Charac to expand it capabilities across Australia, New Zealand and the USA, making components of its app available to a far broader group of pharmacies internationally.
- MedAdvisor will end operations in the UK, transferring its relationships to Charac.
- MedAdvisor has connected with over 3.5 million patients through more than 95% of Australian community pharmacies.
- Charac's app streamlines pharmacy operations onto a cloud-native platform to relieve time pressure, increase efficiency and drive the growth of independent pharmacies.
- Charac has previously secured a £1 million investment from the Royal Mail and £1.2 million from the National Pharmacy Association and pharmacy owners.